Oramed Pharmaceuticals Inc. Stock Deutsche Boerse AG
Equities
OJU1
US68403P2039
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.086 EUR | -4.44% | +0.97% | +4.11% |
Sales 2024 * | 1.3M 1.21M | Sales 2025 * | - | Capitalization | 96.03M 89.61M |
---|---|---|---|---|---|
Net income 2024 * | -10M -9.33M | Net income 2025 * | - | EV / Sales 2024 * | 73.9 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-9.12
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.77% |
1 day | -4.44% | ||
1 week | +0.97% | ||
Current month | -15.69% | ||
1 month | -17.32% | ||
3 months | +5.68% | ||
6 months | +21.86% | ||
Current year | +4.11% |
Managers | Title | Age | Since |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 02-04-11 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 02-04-11 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 13-04-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 02-04-11 |
Miriam Kidron
FOU | Founder | 83 | 02-04-11 |
Leonard Sank
BRD | Director/Board Member | 59 | 07-10-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 2.177 | -0.27% | 0 |
24-04-24 | 2.183 | +1.11% | 0 |
24-04-23 | 2.159 | +2.32% | 0 |
24-04-22 | 2.11 | +4.20% | 0 |
24-04-19 | 2.025 | -6.08% | 0 |
Delayed Quote Deutsche Boerse AG, April 25, 2024 at 02:05 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.64% | 43.84B | |
+4.73% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+5.84% | 25.53B | |
-25.63% | 18.18B | |
-3.88% | 12.29B | |
+25.31% | 12.29B | |
+6.84% | 11.15B |
- Stock Market
- Equities
- ORMP Stock
- OJU1 Stock